These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26552)

  • 1. The metabolism of (2-cyclopentyl-6,7-dichloro-2-methyl-1-oxo-5-indanyloxy)acetic acid in chimpanzee and man.
    Zacchei AG; Wishousky TI; Arison BH; Hitzenberger G
    Drug Metab Dispos; 1978; 6(3):303-12. PubMed ID: 26552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biotransformation of (6,7-dichloro-2-methyl-1-oxo-2-phenyl-5-indanyloxy) acetic acid (MK-196) in the chimpanzee.
    Zacchei AG; Wishousky TI; Arison BH; Fanelli GM
    Drug Metab Dispos; 1976; 4(5):479-89. PubMed ID: 10148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physiological disposition of (2-cyclopentyl-6,7-dichloro-2-methyl-1-oxo-5-indanyloxy)acetic acid in the rat, dog, rhesus monkey, and baboon.
    Zacchei AG; Wishousky TI; Watson LS
    Drug Metab Dispos; 1978; 6(3):313-20. PubMed ID: 26553
    [No Abstract]   [Full Text] [Related]  

  • 4. The physiological disposition of the uricosuric-saluretic agent (6,7-dichloro-2-methyl-1-oxo-2-phenyl-5-indanyloxy)acetic acid (MK-196) in the rat, dog, and monkey.
    Zacchei AG; Wishousky TI
    Drug Metab Dispos; 1976; 4(5):490-8. PubMed ID: 10149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLC determination of a novel polyvalent saluretic agent, (6,7-dichloro-2-methyl-1-oxo-2-phenyl-5-indanyloxy)acetic acid, in biological fluids.
    Zacchei AG; Wishousky T
    J Pharm Sci; 1976 Dec; 65(12):1770-3. PubMed ID: 829793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saluretic and uricosuric effects of (6, 7-dichloro-2-methyl=1-oxo-2-phenyl-5-indanyloxy) acetic acid (MK-196) in the chimpanzee.
    Fanelli GM; Bohn DL; Scriabine A; Beyer KH
    J Pharmacol Exp Ther; 1977 Feb; 200(2):402-12. PubMed ID: 14250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLC determination of the polyvalent saluretic uricosuric agent (2-cyclopentyl-6,7-dichloro-2-methyl-1-oxo-5-indanyloxy)acetic acid in biological fluids.
    Zacchei AG; Wishousky TI
    J Pharm Sci; 1978 Feb; 67(2):162-4. PubMed ID: 413902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
    Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
    Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic disposition of isoxicam in man, monkey, dog, and rat.
    Borondy PE; Michniewicz BM
    Drug Metab Dispos; 1984; 12(4):444-51. PubMed ID: 6148211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological disposition and metabolism of timolol in man and laboratory animals.
    Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ
    Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (1-oxo-2-substituted-5-indanyloxy)acetic acids, a new class of potent renal agents possessing both uricosuric and saluretic activity. A reexamination of the role of sulfhydryl binding in the mode of action of acylphenoxyacetic acidsaluretics.
    Cragoe EJ; Schultz EM; Schneeberg JD; Stokker GE; Woltersdorf OW; Fanelli GM; Watson LS
    J Med Chem; 1975 Feb; 18(2):225-8. PubMed ID: 1120997
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolism of methiothepin in the rat, dog and man].
    Eschenhof E; Meister W; Oesterhelt G; Vetter W
    Arzneimittelforschung; 1976 Feb; 26(2):262-71. PubMed ID: 947211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism in rats and man of piromidic acid, a new antibacterial agent.
    Sekine Y; Miyamoto M; Hashimoto M; Nakamura K
    Xenobiotica; 1976 Mar; 6(3):185-8. PubMed ID: 1274382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic fate of [14C]-brotizolam in the rat, dog, monkey and man.
    Bechtel WD; Mierau J; Brandt K; Förster HJ; Pook KH
    Arzneimittelforschung; 1986 Mar; 36(3A):578-86. PubMed ID: 3718581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man.
    Hucker HB; Stauffer SC; Balletto AJ; White SD; Zacchei AG; Arison BH
    Drug Metab Dispos; 1978; 6(6):659-72. PubMed ID: 33029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of a 1,5-benzodiazepine, triflubazam, by man.
    Alton KB; Grimes RM; Shaw C; Patrick JE; McGuire JL
    Drug Metab Dispos; 1975; 3(5):352-60. PubMed ID: 241616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.